| Recruiting | 3 | 5000 | Europe, RoW | Blinatumomab, Bortezomib, Cyclophosphamide, Cytarabine, Daunorubicin, Myocet, Dexamethasone, Doxorubicin, Etoposide, Fludarabine Phosphate, Ifosfamide, 6-Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Tioguanin, Vincristine, Vindesine, Erwinase | Martin Schrappe, Deutsche Krebshilfe e.V., Bonn (Germany) | Acute Lymphoblastic Leukemia, Pediatric | 07/28 | 07/28 | | |
| Not yet recruiting | 2 | 21 | RoW | Polatuzumab vedotin, Polivy, Bendamustine Hydrochloride, Bendamustine Accord, Bendamustine Glenmark, Bendamustine KABI, Rituximab, Mabthera, Rixathon, Truxima | Czech Lymphoma Study Group | Lymphoma, Mantle-Cell | 08/26 | 08/27 | | |
